Understanding the forces that drive the dynamics of adaptive evolution is a goal of many subfields within evolutionary biology. The fitness landscape analogy has served as a useful abstraction for addressing these topics across many systems, and recent treatments have revealed how different environments can frame the particulars of adaptive evolution by changing the topography of fitness landscapes. In this study, we examine how the larger, ambient genotypic context in which the fitness landscape being modeled is embedded affects fitness landscape topography and subsequent evolution.
In this study, we directly examine empirical fitness landscapes constructed for the 48 study of antimicrobial resistance in dihydrofolate folate reductase (DHFR), an essential 49 bacterial enzyme. Specifically, we employ a data set whereby three orthologous 50 mutations associated with drug resistance were engineered (in all eight possible 51 combinations) into DHFRs from three species of bacteria (Escherichia coli, Listeria 52 grayi, and Chlamydia muridarum). In addition, each of these alleles were then 53 engineered into background bacterial strains containing three different protein quality 54 control (PQC) profiles: wild type, GroEL chaperonins overexpression (GroEL+), and DHFR exposed to high (10 5 µM ) dosages of Pyrimethamine and Cycloguanil against their published IC 50 values [23, 24] and observed a very strong correlation 87 (R 2 > 0.99, p < 10 −35 ). We then used the resulting regression equation to infer relative 88 growth rates at 10 5 µM of Trimethoprim from the IC 50 averages, as shown in Tables 89 1,2,3. Each of these nine sets of eight inferred growth rates (for the eight genotypes of a 90 given species in a given PQC genetic profile) comprise a fitness landscape, as illustrated 91 in Fig. 1 . Note that four of these nine small fitness landscapes contain suboptimal 92 peaks, reflecting the highly epistatic interactions between the three mutations [21] . 93 Table 1 . E. coli data. Measured IC 50 values (in µg/ml) and inferred growth rates (r) for E. coli exposed to 10 with three genetic backgrounds (columns) exposed to 10 5 µM of Trimethoprim. Nodes represent the genotypes indicated in the upper left diagram, where edges connect single-mutational neighbors. Node diameters and shading are proportional to the logarithm of the growth rates shown in Tables 1-3 (no growth rates were available for the square node labeled NA). Simulations (e.g., as shown in Fig. 2 ) starting from the wild type (WT, circled in green) follow the 1-3 step trajectories shown by the thick blue edges; each edge is labeled with the within-path competition (C w ) for that step and the C w for the entire trajectory is shown above each landscape. Each trajectory terminates at either the optimal genotype (i.e., that with the maximum growth rate, circled in red) or a suboptimal peak (circled in cyan).
timestep, the number of individuals of each genotype grows exponentially according to 99 its growth rate with stochastic single locus mutation, and then the entire population is 100 reduced to the carrying capacity by frequency proportionate selection. We note that the 101 classic Wright-Fisher model [25, 26] is a constant population size abstraction of the 102 process implemented directly in DARPS. DARPS is described in more detail in [13] and 103 open source code is available at [27] .
104
For the simulation results reported here, mutation rates were assumed to be when the terminal genotype dominated over 50% of the population (T d ), and (iv) when 115 the terminal genotype became "fixed" (T f ), which we defined to be when it exceeded 116 99% of the population (due to ongoing mutational events, the terminal genotype will 117 never comprise 100% of the population). We ran 1000 stochastic replicates of each 118 simulation on the nine fitness landscapes.
119
Within-path competition 120 We quantified the amount of within-path competition (C w ) along the evolutionary 121 trajectory followed in each of the simulations using the equation derived in [13] , as 122 follows:
where r i represents the growth rate of genotype i along a trajectory comprising m steps 124 from the genotype 1 (the wild type) to genotype m + 1 (the terminal genotype).
125
Results
126
The topographies of all nine unique fitness landscapes are illustrated in terms of relative 127 growth rates in Fig. 1 , where the global peaks (fastest bacterial growth rates) are 128 outlined in red and suboptimal peaks are outlined in cyan. Simulations of evolution on 129 these DHFR landscapes demonstrate large differences in both the direction and speed of 130 adaptive evolution, depending on the larger genotypic context. Although prior work on 131 DHFR landscapes for the malaria parasite revealed that the "greediest" paths are not 132 always those preferred by evolution [13] , in these simulations we found that the 133 greediest paths (shown by the thick blue trajectories in Fig. 1 ) were followed in all of 134 the 1000 stochastic evolutionary simulations on each of these nine small landscapes.
135
One representative simulation for each landscape is shown in Fig. 2 . Below, we point 136 out several notable findings in these results. peaks. For the C. muridarum/WT-PQC landscapes, evolution proceeds along the 167 single-step path to the optimal peak at L28R genotype. In the C. muridarum/∆lon 168 landscape the population also becomes fixed on the L28R genotype, but in this case this 169 is a suboptimal peak that prevents evolution from reaching the optimal peak at 170 P21L:A26T:L28R. In contrast, in C. muridarum/GroEL+ the population follows a 171 two-step path to the optimal peak of A26T:L28R.
172
Effect of species-background on the direction of evolution. 
179
Simulations of evolution demonstrate differences in the speed of 180 adaptive evolution across the 9 fitness landscapes. 181 We illustrate the average number of simulated timesteps it took for the terminal 182 genotype to become dominant in the population (T d ) in Fig. 3 , due to the topographic 183 differences if the landscapes shown in Fig. 1 . Note that evolution to the terminal 184 genotype is universally slower in the L. grayi DHFR background than the other two 185 species backgrounds, but that the relative evolutionary speeds in E. coli and C. although the E. coli growth rates are much higher than those of L. grayi and C.
191
muridarum across all PQC backgrounds ( Fig. 1 and Table 1 ), evolution does not always 192 proceed fastest along these landscapes (Fig. 3) . This is an important reminder that the 193 speed of evolution is not a function of the fitness of individual genotypes, but is largely 194 governed by the differences in fitnesses of adjacent genotypes in an evolutionary 195 trajectory [13] , as quantified by the within-path competition (C w ) shown in Eq. (1).
196
For example, in these simulations T d is shown be a slightly sublinear function of Cw 197 ( Fig. 4 , R 2 > 0.99, p ≈ 0). Despite the stochastic nature of these simulations, T d can be 198 seen to be very consistent across the 1000 repetitions of each simulation of these very 199 large populations (Fig. 4) . The competition values along each individual step of the 200 trajectories followed are shown in blue in Fig. 1 , with the total C w for each trajectory 201
shown above each landscape in Fig. 1 . Species differences in protein backbone alters the speed and 211 direction of evolution.
212
Evolutionary simulations on these landscapes illustrate how evolution occurs differently 213 across species. With regard to the evolution of drug resistance, these findings indicate 214 that even subtle differences in the amino acid sequence for otherwise conserved enzymes 215
can have a powerful effect on how evolution occurs (both speed and direction). This 216 implies that we cannot assume that even closely related microbial pathogens will evolve 217 resistance to drugs using the same evolutionary trajectory, as the fitness landscape 218 underlying resistance may be different. This might be complicating news for the 219 burgeoning field of resistance management: instead of being able to adopt a 220 one-size-fits-all approach to managing resistance, we may have to engineer our 221 managements to very specific genotypic contexts.
222
Differences in protein quality control alter the speed and 223 direction of evolution.
224
Two thirds of the landscapes with PQC modifications had longer evolutionary 225 trajectories than in the wild type, and in L. grayi they even had different initial 226 directions. This supports the idea that global protein quality control regulation may 227 have prescribed ways of altering the landscape, maybe related to the way they influence 228 the lifetime and performance of enzymes in a cell [21, 28] . In this setting, mutations may 229 alter resistance patterns not because they affect the way a drug binds but because they 230 affect the interaction between a protein effector and the PQC machinery. This would 231 suggest a mechanism for how resistance in microbes can be so biochemically and 232 biophysically diverse, even in well-characterized systems like DHFR and antifolates: an 233 enzyme might avoid the effects of a drug through altering its interaction with other 234 genes maybe even in lieu of altering the binding of a antibiotic drug.
235
General note on the speed of evolution.
236
The speed of evolution from the wild type genotype to the terminal genotype in 237 evolutionary simulations is shown to vary greatly across different genotypic contexts, 238 and in a manner that is not related to the absolute fitnesses of the nodes in the respective landscapes. More broadly, this study affirms the relationship between 240 within-path competition (C w , defined by Eq. (1)) and the speed of evolution 241 (determined via simulation) [13] . As a general observation, studies that examine the 242 speed of evolution have been all but ignored in the study of empirical fitness landscapes, 243
although it has recently been demonstrated to be an important property of evolutionary 244 dynamics [13] . In particular, discussions that invoke empirical fitness landscapes in This suggests that future efforts at "resistance management" need to consider very 262 specific genomic and genetic details about the population being managed before 263 rigorous and effective management strategies are engineered.
264
In addition, our results highlight how particular "off target" mutations (in our study, 265 PQC modifications) can have powerful influences on evolutionary outcomes.
266
Consequently, genomic screens for "resistance mutations" should focus on potential 267 signals across the genome, rather than a singular focus on genes that are the 268 presumptive target of therapy. Our results illustrate that there are multiple ways to subvert the effects of a drug, sometimes involving genes and gene networks that are not 270 intuitively (or biophysically) linked to the phenotype of interest (in this case, protein 271 quality control genes having no specific connection to DHFR activity). Similarly, our 272 results underscore the potential perils of engineering mutations associated with a given 273 phenotype into different genomic backgrounds, as in CRISPR-mediated genetic 274 engineering. In such scenarios, differences in genomic background of strains in which a 275
given SNP is being engineered can not only influence the effect of the mutation being 276 introduced, but also, the downstream evolution of different populations.
277
Lastly, our results speak to the notion that small genetic differences between 278 populations may be sufficient to induce larger downstream divergence, eventually 279 leading to speciation. Specifically, our study is consistent with the expectation that 280 reproductive isolation arises rapidly in rugged fitness landscapes (e.g., in a 281 Bateson-Dobzhansky-Muller framework [29] , or holey landscape [30] 
